Salud financiera de hoja de balance de Integra LifeSciences Holdings
Salud financiera controles de criterios 2/6
Integra LifeSciences Holdings tiene un patrimonio de accionistas total de $1.5B y una deuda total de $1.8B, lo que sitúa su ratio deuda-patrimonio en 118.9%. Sus activos y pasivos totales son $4.1B y $2.5B respectivamente. El BAIT de Integra LifeSciences Holdings es de $193.9M, por lo que su ratio de cobertura de intereses es de 4.2. Tiene efectivo e inversiones a corto plazo que ascienden a $277.6M.
Información clave
118.9%
Ratio deuda-patrimonio
US$1.81b
Deuda
| Ratio de cobertura de intereses | 4.2x |
| Efectivo | US$277.60m |
| Patrimonio | US$1.52b |
| Total pasivo | US$2.54b |
| Activos totales | US$4.07b |
Actualizaciones recientes sobre salud financiera
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Recent updates
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise
Nov 05Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Oct 24Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S
Sep 08Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($1.1B) de IART superan a sus pasivos a corto plazo ($912.6M).
Pasivo a largo plazo: Los activos a corto plazo ($1.1B) de IART no cubren sus pasivos a largo plazo ($1.6B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de IART (100.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de IART ha crecido de 107.3% a 118.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de IART no está bien cubierta por el flujo de caja operativo (7.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de IART están bien cubiertos por el BAIT (4.2x cobertura).